Innate Pharma
Clinical-stage biotech developing immunotherapies for cancer using the innate immune system.
IPH | PA
Overview
Corporate Details
- ISIN(s):
- FR0010331421 (+1 more)
- LEI:
- 9695002Y8420ZB8HJE29
- Country:
- France
- Address:
- 117 AVENUE DE LUMINY, 13009 MARSEILLE
- Website:
- http://www.innate-pharma.com/
- Sector:
- Manufacturing
Description
Innate Pharma is a clinical-stage, oncology-focused biotechnology company that develops immunotherapies for cancer patients. The company's scientific approach is centered on leveraging the innate immune system, particularly Natural Killer (NK) cells, to create novel treatments. Its innovative pipeline is composed of antibody-based therapeutics, including first-in-class monoclonal antibodies, antibody-drug conjugates (ADCs), and multi-specific NK cell engagers based on its proprietary ANKET® platform. Key clinical programs include lacutamab (anti-KIR3DL2), monalizumab (anti-NKG2A) in partnership with AstraZeneca, and a portfolio of NK cell engagers targeting various hematological malignancies and solid tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2009-09-18 18:03 |
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) annonce aujourd’hui qu’à …
|
French | 30.9 KB | ||
| 2009-09-18 18:03 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces today the signatur…
|
English | 31.7 KB | ||
| 2009-09-17 18:46 |
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) annonce sa participation …
|
French | 36.3 KB | ||
| 2009-09-17 18:46 |
Innate Pharma announces that it will participate to the MidCap Event on 21-22 S…
|
English | 35.4 KB | ||
| 2009-09-11 07:00 |
Inserm Transfert et Innate Pharma (Euronext : IPH) s’engagent dans un partenari…
|
French | 38.0 KB | ||
| 2009-09-11 07:00 |
Inserm Transfert and Innate Pharma (Euronext : IPH) enter into an innovative pa…
|
English | 37.1 KB | ||
| 2009-09-04 19:34 |
Rapport financier semestriel au 30 juin 2009
|
French | 157.0 KB | ||
| 2009-09-04 19:34 |
Innate Pharma SA: Interim Financial Report June 30, 2009
|
English | 154.1 KB | ||
| 2009-08-31 18:40 |
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) annonce aujourd’hui ses r…
|
French | 85.2 KB | ||
| 2009-08-31 18:40 |
Innate Pharma SA (Euronext Paris: FR0010331421 – IPH) announces today its finan…
|
English | 79.6 KB | ||
| 2009-08-27 17:45 |
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce l'initiation de …
|
French | 45.2 KB | ||
| 2009-08-27 17:45 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces today the start of…
|
English | 44.2 KB | ||
| 2009-06-23 18:30 |
Innate Pharma SA (Euronext Paris : FR0010331421 – IPH) annonce les résultats de…
|
French | 41.7 KB | ||
| 2009-06-23 18:30 |
Innate Pharma (Euronext Paris: FR0010331421 – IPH) announces today the outcome …
|
English | 40.7 KB | ||
| 2009-06-15 07:00 |
Innate Pharma SA et ses partenaires annoncent le démarrage opérationnel de PLAT…
|
French | 52.2 KB |
Automate Your Workflow. Get a real-time feed of all Innate Pharma filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Innate Pharma
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Innate Pharma via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-01-10 | N/A | Other | Buy | 6,000 | N/A |
| 2024-01-02 | N/A | Other | Buy | 20,000 | N/A |
Peer Companies
